Detalhe da pesquisa
1.
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis.
Gut
; 69(10): 1900-1902, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843789
2.
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
Infect Agent Cancer
; 19(1): 21, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693556
3.
Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus.
Expert Rev Gastroenterol Hepatol
; 17(5): 499-507, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975382
4.
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis.
BJS Open
; 7(1)2023 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802244
5.
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFßR2.
Clin Transl Oncol
; 25(10): 2960-2971, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024636
6.
Second-line treatment options for hepatocellular carcinoma: current state and challenges for the future.
Expert Opin Investig Drugs
; 31(11): 1151-1167, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437752
7.
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges.
J Clin Transl Hepatol
; 10(5): 955-964, 2022 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36304509
8.
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy.
J Clin Transl Hepatol
; 10(1): 147-158, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233384
9.
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC.
Front Oncol
; 11: 783339, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35127490
10.
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.
Aliment Pharmacol Ther
; 57(7): 810-812, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913504
11.
The upward trend in the immunotherapy utilization for hepatobiliary cancers.
Hepatobiliary Surg Nutr
; 10(5): 692-695, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34760976